Regenerative Therapy in Osteoarthritis
Regenerative Therapy in Osteoarthritis
Osteoarthritis( OA) is the most common common disorder in the world. It generally affects the knee & elbow and current treatment options are limited and substantially focusing on symptom relief. It's now known that Osteoarthritis is the result of both biological and mechanical events that disrupt catabolic and anabolic processes in the joints. lately, exploration in regenerative therapeutics has been gaining further interest of its eventuality to restore the normal structure and functions of the following towel injury. The use of Mesenchymal Stem cells in knee Osteoarthritis seems promising as it's suitable to separate into a wide variety of cells, similar as myocytes, tendocytes and ligament cells. The thing is to use the body’s own form mechanisms in order to heal the tissues that were preliminarily irrecoverable. The available exploration on similar therapies, similar as mesenchymal stem cells, platelet rich tube, hyaluronic acid, and prolotherapy, further exploration is demanded to establish the use of these therapies for the treatment of knee OA.
Related Conference of Regenerative Therapy in Osteoarthritis
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Regenerative Therapy in Osteoarthritis Conference Speakers
Recommended Sessions
- 3D Bio-Printing and Organ Printing
- Advances in Stem Cells and their Niches
- Bio Banking
- Biomaterials and Biomedical Applications
- Bone Marrow Transplantation
- Cancer Stem Cell and Oncology
- Cell and Gene Therapy
- Cell Biology
- Cell Therapy for Cardiovascular and Neurological Disorders
- COVID-19 and Convalescent Plasma
- Dental Stem Cell
- Effect of Aging on Stem Cells
- Novel Stem Cell Techniques
- Regenerative Medicine research and development
- Regenerative Therapy in Osteoarthritis
- Stem Cell in Drug Discovery
- Stem Cells
- Stem Cells and Disease Modelling
- Stem Cells and Veterinary Applications
- Tissue Engineering
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
